Free equity investment tool of Japanese companies

HOME >
Company List >
Central Glass+小林製薬 (Annual ) >
Financial Statement Details

Financial Statement Details: Annual; First quarter; Second quarter; Third quarter

Sponsored Link

Related Company: TOAGOSEI CO; T&K TOKA; MANDOM; Hitachi Chemical; 日油; 積水樹脂; TOWA PHARMACEUTICAL; Dr.Ci:Labo; Nichi-Iko Pharmaceutical; NITTO FC; 東京応化工業; Noevir Holdings; NATOCO; KANEKA; 栄研化学

EDIUNET Related Ranking: EDIUNET; EDIUNET Credit Rating; EDIUNET Industry Avg; EDIUNET Prefectures; Yuho! Industry

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

RSS

Company RSS

Daily RSS

Sponsored Link

Recently Download Chart: SANKEI CHEMICAL

Nissan Motor

Yushiro Chemical Indutry

Renesas Electronics

PIONEER etc.

Financial Statement Details: Central Glass+小林製薬 (Annual )

Two or more periods are displayed by each of subject collectively.Two or more companies can be compared and financial statement data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

*Free Download Financial Statement data

F/S Outline: Central Glass+小林製薬 (Annual )

Switch ViewU-Chart U-Chart and F/S F/S

U-Chart	Central Glass (2013-03-31)	小林製薬 (2013-03-31)
Consolidated :Balance sheet (B/S) Consolidated \| Non-Consolidated \| Small \| Large
Cash etc. Other Current Assets Tangible Assets Intangible Assets Investment etc. Current Liabilities Fixed Liabilities Capital stock Capital surplus etc.	IN(Right half), OUT(Left half), BALANCE(Net Assets)
	* Total: ¥ 237 B * Net: ¥ 125 B (Ratio: 52.83%)	* Total: ¥ 157 B * Net: ¥ 114 B (Ratio: 73.12%)
Financial Statement Details	Central Glass (2013-03-31)	小林製薬 (2013-03-31)
Cash etc.	¥ 23 B	¥ 45 B
Other Current Assets	¥ 86 B	¥ 48 B
Tangible Assets	¥ 87 B	¥ 13 B
Intangible Assets	¥ 954 M	¥ 5 B
Investment etc.	¥ 38 B	¥ 43 B
Total Assets	¥ 237 B	¥ 157 B
Current Liabilities	¥ 71 B	¥ 34 B
Fixed Liabilities	¥ 40 B	¥ 7 B
Capital stock	¥ 18 B	¥ 3 B
Capital surplus etc.	¥ 107 B	¥ 111 B
Liabilities and net assets	¥ 237 B	¥ 157 B
Consolidated :Income statement (P/L) Consolidated \| Non-Consolidated \| Small \| Large
U-Chart	Central Glass (2013-03-31)	小林製薬 (2013-03-31)
Sales Cost of Sales Other income SG&A Other expenses Net income	IN(Right half), OUT(Left half), BALANCE(Net Income)
	* Sales: ¥ 173 B * Income: ¥ 4 B (Ratio: 2.80%)	* Sales: ¥ 121 B * Income: ¥ 12 B (Ratio: 10.02%)
Financial Statement Details	Central Glass (2013-03-31)	小林製薬 (2013-03-31)
Sales	¥ 173 B	¥ 121 B
Cost of Sales	¥ 131 B	¥ 51 B
Gross profit	¥ 41 B	¥ 69 B
Other income	¥ 4 B	¥ 5 B
SG&A	¥ 34 B	¥ 52 B
Other expenses	¥ 6 B	¥ 10 B
Net income	¥ 4 B	¥ 12 B
Consolidated :Cash flow statement (C/F) Consolidated \| Non-Consolidated \| Small \| Large
U-Chart	Central Glass (2013-03-31)	小林製薬 (2013-03-31)
Operating CF Investment CF Financial CF Foreign Exchange Effects Net Change in Cash	IN(Right half), OUT(Left half), BALANCE(Net Change in Cash)
	* OCF: ¥ 14 B * Cash: ¥ +5 B	* OCF: ¥ 9 B * Cash: ¥ -20 B
Financial Statement Details	Central Glass (2013-03-31)	小林製薬 (2013-03-31)
Operating CF	¥ 14 B	¥ 9 B
Investment CF	¥ -13 B	¥ -26 B
Financial CF	¥ 4 B	¥ -3 B
Foreign Exchange Effects	¥ 509 M	¥ 578 M
Net Change in Cash	¥ 5 B	¥ -20 B
Consolidated :Shareowners' equity (S/S) Consolidated \| Non-Consolidated \| Small \| Large
U-Chart	Central Glass (2013-03-31)	小林製薬 (2013-03-31)
Issuance of new shares Dividends from surplus Net income Purchase of treasury stock Other Change in Stockholders Equity Other Change in Net Assets Net Change in Net Assets	IN(Right half), OUT(Left half), BALANCE(Net Change in Net Assets)
	* Income: ¥ 4 B * Net: ¥ +8 B	* Income: ¥ 12 B * Net: ¥ +12 B
Financial Statement Details	Central Glass (2013-03-31)	小林製薬 (2013-03-31)
Issuance of new shares	-	-
Dividends from surplus	¥ -1 B	¥ -3 B
Net income	¥ 4 B	¥ 12 B
Purchase of treasury stock	¥ -7 M	¥ -1 M
Other Change in Stockholders Equity	-	-
Other Change in Net Assets	¥ 4 B	¥ 4 B
Net Change in Net Assets	¥ 8 B	¥ 12 B

U-Chart	Central Glass (2013-03-31)	小林製薬 (2011-03-31)
Non-Consolidated :Balance sheet (B/S) Consolidated \| Non-Consolidated \| Small \| Large
Cash etc. Other Current Assets Tangible Assets Intangible Assets Investment etc. Current Liabilities Fixed Liabilities Capital stock Capital surplus etc.	IN(Right half), OUT(Left half), BALANCE(Net Assets)
	* Total: ¥ 205 B * Net: ¥ 121 B (Ratio: 59.13%)	* Total: ¥ 125 B * Net: ¥ 86 B (Ratio: 68.73%)
Financial Statement Details	Central Glass (2013-03-31)	小林製薬 (2011-03-31)
Cash etc.	-	¥ 29 B
Other Current Assets	-	¥ 46 B
Tangible Assets	-	¥ 6 B
Intangible Assets	-	¥ 1 B
Investment etc.	¥ 205 B	¥ 40 B
Total Assets	¥ 205 B	¥ 125 B
Current Liabilities	¥ 83 B	¥ 33 B
Fixed Liabilities	-	¥ 6 B
Capital stock	-	¥ 3 B
Capital surplus etc.	¥ 121 B	¥ 82 B
Liabilities and net assets	¥ 205 B	¥ 125 B
Non-Consolidated :Income statement (P/L) Consolidated \| Non-Consolidated \| Small \| Large
U-Chart	Central Glass (2013-03-31)	小林製薬 (2011-03-31)
Sales Cost of Sales Other income SG&A Other expenses Net income	IN(Right half), OUT(Left half), BALANCE(Net Income)
	* Sales: ¥ 100 B * Income: ¥ 6 B (Ratio: 6.44%)	* Sales: ¥ 109 B * Income: ¥ 6 B (Ratio: 6.03%)
Financial Statement Details	Central Glass (2013-03-31)	小林製薬 (2011-03-31)
Sales	¥ 100 B	¥ 109 B
Cost of Sales	¥ 93 B	¥ 52 B
Gross profit	¥ 6 B	¥ 57 B
Other income	-	¥ 2 B
SG&A	-	¥ 43 B
Other expenses	-	¥ 10 B
Net income	¥ 6 B	¥ 6 B
Non-Consolidated :Shareowners' equity (S/S) Consolidated \| Non-Consolidated \| Small \| Large
U-Chart	Central Glass (2013-03-31)	小林製薬 (2011-03-31)
Issuance of new shares Dividends from surplus Net income Purchase of treasury stock Other Change in Stockholders Equity Other Change in Net Assets Net Change in Net Assets	IN(Right half), OUT(Left half), BALANCE(Net Change in Net Assets)
	-	* Income: ¥ 6 B * Net: ¥ +5 B
Financial Statement Details	Central Glass (2013-03-31)	小林製薬 (2011-03-31)
Issuance of new shares	-	-
Dividends from surplus	-	¥ -2 B
Net income	-	¥ 6 B
Purchase of treasury stock	-	-
Other Change in Stockholders Equity	-	¥ -1 M
Other Change in Net Assets	-	¥ 1 B
Net Change in Net Assets	-	¥ 5 B

Related Information: Central Glass 小林製薬

Statement Type: Annual : Central Glass+小林製薬; First quarter : Central Glass+小林製薬; Second quarter : Central Glass+小林製薬; Third quarter : Central Glass+小林製薬

Analysis Menu: Outline : Central Glass+小林製薬; Statement : Central Glass+小林製薬; Rating : Central Glass+小林製薬; Indicator : Central Glass+小林製薬; Download : Central Glass+小林製薬

Industry Comparison Ranking: Chemicals - EDIUNET Industry Rankings; Chemicals - EDIUNET Credit Rating; Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company: Yamaguchi - EDIUNET Prefectures; Yamaguchi宇部市 - EDIUNET Prefectures; Osaka - EDIUNET Prefectures; Osaka大阪市 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals): 1/23 Chemicals (Milbon:AA→AAA); 1/17 Chemicals (Kawaguchi Chemica..; 1/15 Chemicals (HOKKO CHEMICAL IN..; 1/10 Chemicals (OSAKA ORGANIC CHE..; 1/9 Chemicals (SANKO GOSEI:A); 12/27 Chemicals (Niitaka:A); 12/18 Chemicals (KUMIAI CHEMICAL I..; 12/12 Chemicals (IHARA CHEMICAL IN..; 12/11 Chemicals (Konoshima Chemica..; 12/10 Chemicals (NATOCO:AA)

Ticker	Market	Industry	Month	report	Rating
Central Glass	4044	TSE 1st	Chemicals	3	Annual	BBB
小林製薬	4967	TSE 1st	Chemicals	3	Annual	AA

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .

Free equity investment tool of Japanese companies

Financial Statement Details: Central Glass+小林製薬 (Annual )

F/S Outline: Central Glass+小林製薬 (Annual )

Consolidated :Balance sheet (B/S) Consolidated | Non-Consolidated | Small | Large

Consolidated :Income statement (P/L) Consolidated | Non-Consolidated | Small | Large

Consolidated :Cash flow statement (C/F) Consolidated | Non-Consolidated | Small | Large

Consolidated :Shareowners' equity (S/S) Consolidated | Non-Consolidated | Small | Large

Non-Consolidated :Balance sheet (B/S) Consolidated | Non-Consolidated | Small | Large

Non-Consolidated :Income statement (P/L) Consolidated | Non-Consolidated | Small | Large

Non-Consolidated :Shareowners' equity (S/S) Consolidated | Non-Consolidated | Small | Large

Related Information: Central Glass 小林製薬

Related company's newest statement

Company Information

Related Company

関連する株式投資情報

EDIUNET Caution